| Kumar, Mukesh |
NCT05407389: Rollover Extension Clinical Trial To Evaluate The Long-Term Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With CKD IV Completing The US-APR2020-01 Study |
|
|
| Recruiting | 2/3 | 600 | US | KT-301 (formerly US-APR2020) | Kibow Pharma | Chronic Kidney Disease stage4 | 12/23 | 03/24 | | |
NCT04913272: Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IV |
|
|
| Recruiting | 2 | 630 | US | US-APR2020, Placebo | Kibow Pharma | Chronic Kidney Disease stage4 | 09/23 | 12/23 | | |
NCT04750252: Safety and Tolerability of StroMelâ„¢ in Subjects With Moderate to Severe Osteoarthritis of the Knee Joint |
|
|
| Not yet recruiting | 1/2 | 20 | US | StroMel | Akan Biosciences, LLC | Osteo Arthritis Knee | 12/22 | 12/22 | | |
| Gabriel |
NCT05814016: A Study of Danavorexton in People With Obstructive Sleep Apnea After General Anesthesia for Abdominal Surgery |
|
|
| Recruiting | 2 | 180 | US | Danavorexton, TAK-925, Placebo | Takeda | Sleep Apnea | 01/25 | 03/25 | | |
| Completed | N/A | 248 | US | AlloSure | CareDx | Kidney Transplant Rejection | 03/23 | 10/23 | | |
